期刊
CHEMICAL REVIEWS
卷 118, 期 4, 页码 1917-1950出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.chemrev.7b00534
关键词
-
资金
- NIH [R21-CA205322, R01-HL113156, R01-CA204019, R01-EB010011, R01-EB00462605A1, P01-CA069246, CA179563, K99-CA201248-02]
- Liz Tilberis Award-Ovarian Cancer Research Fund
- Institute for Pancreatic Cancer Research at MGH
- Lustgarten Foundation
- MGH Scholar Fund
- National Research Foundation of Korea [NRF-2017M3A9B4025699, NRF-2017M3A9B4025709]
- Institute for Basic Science [IBS-R026-D1]
- Singapore government [R-722-000-005-133, NMRC/TCR/016-NNI/2016]
- NUS Early Career Research Award
- National Research Foundation of Korea [2017M3A9B4025709] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
Extracellular vesicles (EVs) are diverse, nanoscale membrane vesicles actively released by cells. Similar-sized vesicles can be further classified (e.g., exosomes, microvesicles) based on their biogenesis, size, and biophysical properties. Although initially thought to be cellular debris, and thus under-appreciated, EVs are now increasingly recognized as important vehicles of intercellular communication and circulating biomarkers for disease diagnoses and prognosis. Despite their clinical potential, the lack of sensitive preparatory and analytical technologies for EVs poses a barrier to clinical translation. New analytical platforms including molecular ones are thus actively being developed to address these challenges. Recent advances in the field are expected to have far-reaching impact in both basic and translational studies. This article aims to present a comprehensive and critical overview of emerging analytical technologies for EV detection and their clinical applications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据